Cost of transfusion-dependent myelodysplastic syndromes (MDS) in Germany

被引：0
|
作者：
Kuehne, F.
Mittendorf, T.
Voelkl, M.
Lipp, R.
Germing, U.
Vioni-Niemeyer, A.
von der Schulenburg, J. M.
机构：
[1] Leibniz Univ Hannover, Ctr Hlth Econ, Hannover, Germany
[2] Celgene GmbH, Munich, Germany
[3] Innovat Oncol Res & Consulting GmbH, Hamburg, Germany
[4] Univ Dusseldorf, Ctr Haematol & Oncol, Dept Hematol Oncol & Clin Immunol, D-4000 Dusseldorf, Germany
来源：
LEUKEMIA RESEARCH | 2007年 / 31卷
关键词：
D O I：
10.1016/S0145-2126(07)70201-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S111 / S111
页数：1
相关论文
共 50 条
  • [1] Cost of transfusion-dependent myelodysplastic syndromes (MDS) in Germany
    Kuehne, F. C.
    Mittendorf, T.
    Voelkl, M.
    Lipp, R.
    Germing, U.
    Vioni-Niemeyer, A.
    Von der Schulenburg, J. M.
    VALUE IN HEALTH, 2007, 10 (06) : A282 - A282
  • [2] Cost of transfusion-dependent myelodysplastic syndromes (MDS) in Germany
    Kuehne, C.
    Mittendorf, T.
    Voelk, M.
    Lipp, R.
    Gerning, U.
    Vionniemeyer, A.
    von der Schulenberg, J. M. Graf
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 547 - 547
  • [3] Do ESAs Reduce Transfusion Need among Transfusion-Dependent Myelodysplastic Syndromes (MDS) Patients?
    Smith, Sheila R. Weiss
    Sato, Masayo
    Baer, Maria R.
    Ke, Xuehua
    Gore, Steven D.
    Davidoff, Amy
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S282 - S283
  • [4] Cost-effectiveness of lenalidomide in treating patients with transfusion-dependent myelodysplastic syndromes (MDS) in the United States.
    Goss, T. F.
    Szende, A.
    Schaefer, C. P.
    Totten, P. J.
    Wang, M. Y.
    List, A. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 332S - 332S
  • [5] Cost-effectiveness of lenalidomide in the treatment of patients with transfusion-dependent myelodysplastic syndromes (MDS) in the United States.
    Goss, TF
    Szende, A
    Brueckner, J
    Wang, M
    Schaefer, C
    List, AF
    BLOOD, 2005, 106 (11) : 388A - 389A
  • [6] Cost of transfusion-dependent myelodysplastic syndrome (MDS) from a German payer's perspective
    Kuehne, Felicitas
    Mittendorf, Thomas
    Germing, Ulrich
    Tesch, Hans
    Weinberg, Reiner
    Grabenhorst, Ulrich
    Mohr, Andreas
    Lipp, Rainer
    von der Schulenburg, Johann Matthias
    ANNALS OF HEMATOLOGY, 2010, 89 (12) : 1239 - 1247
  • [7] Cost of transfusion-dependent myelodysplastic syndrome (MDS) from a German payer’s perspective
    Felicitas Kühne
    Thomas Mittendorf
    Ulrich Germing
    Hans Tesch
    Reiner Weinberg
    Ulrich Grabenhorst
    Andreas Mohr
    Rainer Lipp
    Johann Matthias von der Schulenburg
    Annals of Hematology, 2010, 89 : 1239 - 1247
  • [8] Rationale for Therapy Discontinuation in Patients with Lower-Risk Transfusion-Dependent Myelodysplastic Syndromes (MDS)
    Gerds, Aaron T.
    Gupta, Shaloo
    Binder, Gary
    Sekeres, Mikkael A.
    Nazha, Aziz
    Carraway, Hetty E.
    Hawthorne, Stephanie
    King-Concialdi, Kristen
    McGuire, Michael
    BLOOD, 2016, 128 (22)
  • [9] Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes
    Roy, Noemi B. A.
    Myerson, Saul
    Schuh, Anna H.
    Bignell, Patricia
    Patel, Roger
    Wainscoat, Jim S.
    McGowan, Simon
    Marchi, Emanuele
    Atoyebi, Wale
    Littlewood, Tim
    Chacko, Joseph
    Vyas, Paresh
    Killick, Sally B.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (04) : 521 - 524
  • [10] Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes
    Jansen, AJG
    Essink-Bot, ML
    Beckers, EAM
    Hop, WCJ
    Schipperus, MR
    van Rhenen, DJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (02) : 270 - 274
12345